Target intelligence / Profile preview

NHP2 ribonucleoprotein pseudogene 2 (NHP2P2)

Target: NHP2P2
Molecular classification: Other (Pseudogene)

Overview

NHP2 ribonucleoprotein pseudogene 2 (NHP2P2, also known as TCAG_30283) is a pseudogene in the human genome and does not encode a functional protein[4]. This gene is related by sequence to the active NHP2 ribonucleoprotein gene, which is crucial for ribosome biogenesis and telomere maintenance[1][3]. As a pseudogene, NHP2P2 lacks experimentally validated biological functions, is not considered a therapeutic target, and does not play a role in disease, interact with drugs, or serve as a biomarker. Its main relevance is as a non-functional genomic element and should not be conflated with the functional NHP2 ribonucleoprotein.

Other names: TCAG_30283NHP2P2

Beyond the preview

Go deeper on NHP2 ribonucleoprotein pseudogene 2 (NHP2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NHP2 ribonucleoprotein pseudogene 2 (NHP2P2).

Explore the full profile